Optimizing the Design and Analysis of Future AKI Trials

Area of Science:

• Nephrology
• Clinical Trials Methodology
• Critical Care Medicine

Background:

• Acute kidney injury (AKI) is a significant clinical syndrome linked to increased morbidity and mortality, especially in critically ill and perioperative patients.
• Existing AKI clinical trials frequently yield inconclusive results, struggling to detect meaningful treatment effects due to statistical limitations.
• A major hurdle in AKI research is the inherent heterogeneity in its pathobiology, causes, presentation, and clinical progression, complicating the development of effective interventions.

Purpose of the Study:

• To review existing barriers to effective clinical trial design and implementation for acute kidney injury (AKI).
• To explore novel strategies and approaches for improving the design and execution of AKI clinical trials.
• To propose a roadmap with actionable recommendations for advancing AKI clinical trial methodologies.

Main Methods:

• Review of novel trial designs including adaptive, pragmatic, and platform trial designs.
• Discussion of innovative clinical trial analysis techniques, such as Bayesian analysis.
• Assessment of methods for evaluating treatment response heterogeneity among trial participants.

Main Results:

• Adaptive trials enhance knowledge acquisition per participant.
• Pragmatic trials facilitate large-scale enrollment for detecting subtle treatment effects.
• Platform trials enable simultaneous investigation of multiple research questions within a single framework.

Conclusions:

• Adoption of novel trial designs and analysis methods can overcome key challenges in AKI research.
• Implementing these strategies will optimize learning from AKI trials and minimize the risk of overlooking significant treatment benefits or harms.
• A proposed roadmap aims to guide future AKI trial planning and execution.